Výsledky vyhledávání - "Eccles, Diana E."

Thec. 5096G>A p.Arg1699Gln (R1699Q) intermediate risk variant : breast and ovarian cancer risk estimation and recommendations for clinical management from the ENIGMA consortium

Autor: Moghadasi, Setareh, Meeks, Huong D., Vreeswijk, Maaike P G, Janssen, Linda A.M., Borg, Åke, Ehrencrona, Hans, Paulsson-Karlsson, Ylva, Wappenschmidt, Barbara, Engel, Christoph, Gehrig, Andrea, Arnold, Norbert, Van Overeem Hansen, Thomas, Thomassen, Mads, Jensen, Uffe Birk, Kruse, Torben A., Ejlertsen, Bent, Gerdes, Anne Marie, Pedersen, Inge Søkilde, Caputo, Sandrine M., Couch, Fergus J., Hallberg, Emily J., Van Den Ouweland, Ans M W, Collée, J. Margriet, Teugels, Erik, Adank, Muriel A., van der Luijt, Rob B., Mensenkamp, Arjen R., Oosterwijk, Jan C., Blok, Marinus J., Janin, Nicolas, Claes, Kathleen B M, Tucker, Kathy, Viassolo, Valeria, Toland, Amanda Ewart, Eccles, Diana E., Devilee, Peter, Van Asperen, Christie J., Spurdle, Amanda B., Goldgar, David E., García, Encarna Gómez

Publikováno v: Journal of Medical Genetics, 55(1), 15. BMJ Publishing Group

BACKGROUND: We previously showed that theBRCA1variant c.5096G>A p.Arg1699Gln (R1699Q) was associated with an intermediate risk of breast cancer (BC) and ovarian cancer (OC). This study aimed to assess these cancer risks for R1699Q carriers in a large

Vyhledávací nástroje:

Upřesnit hledání